New Business Model to Address the Challenges of the Continuing COVID-19 Crisis
one question if huge amount of money is invested in companies to strengthen the business why most of the companies business model not changing as i hardly see any change on ground as a pharma professional. second what kind of preparation a on field pharma professional should do to adopt to the change if any? regards
It was a pleasure listening to Subroto Banerjee's insights into the Pharma Industry as a whole and hopeful to know about the global investments in this sector.
Excellent insights on equity market and venture capital of the industry during pandemic...
Thanks..please share a email reminder one day prior to this event scheduled
Thanks..please share a email reminder one day prior to this event scheduled on Saturday.